SE411453B - Forfarande for framstellning av 3-fluorcefalosporiner - Google Patents

Forfarande for framstellning av 3-fluorcefalosporiner

Info

Publication number
SE411453B
SE411453B SE7403307A SE7403307A SE411453B SE 411453 B SE411453 B SE 411453B SE 7403307 A SE7403307 A SE 7403307A SE 7403307 A SE7403307 A SE 7403307A SE 411453 B SE411453 B SE 411453B
Authority
SE
Sweden
Prior art keywords
fluorcephalosporins
procedure
preparation
Prior art date
Application number
SE7403307A
Other languages
English (en)
Swedish (sv)
Other versions
SE7403307L (no
Inventor
G A Koppel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7403307L publication Critical patent/SE7403307L/xx
Publication of SE411453B publication Critical patent/SE411453B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7403307A 1974-02-06 1974-03-12 Forfarande for framstellning av 3-fluorcefalosporiner SE411453B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US439206A US3926978A (en) 1974-02-06 1974-02-06 Process for preparing 3-fluorocephalosporins

Publications (2)

Publication Number Publication Date
SE7403307L SE7403307L (no) 1975-08-07
SE411453B true SE411453B (sv) 1979-12-27

Family

ID=23743733

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7403307A SE411453B (sv) 1974-02-06 1974-03-12 Forfarande for framstellning av 3-fluorcefalosporiner

Country Status (32)

Country Link
US (1) US3926978A (no)
JP (1) JPS612678B2 (no)
AR (1) AR202209A1 (no)
AT (1) AT329181B (no)
BE (1) BE813169A (no)
BG (1) BG25091A3 (no)
BR (1) BR7404085A (no)
CA (1) CA1017741A (no)
CH (1) CH598263A5 (no)
DD (1) DD117465A5 (no)
DE (1) DE2417988A1 (no)
DK (1) DK119874A (no)
EG (1) EG11061A (no)
ES (1) ES427235A1 (no)
FI (1) FI99474A (no)
FR (1) FR2259826B1 (no)
GB (1) GB1462944A (no)
GT (1) GT197432532A (no)
HU (1) HU167748B (no)
IE (1) IE38980B1 (no)
IL (1) IL44361A (no)
IN (1) IN139927B (no)
MW (1) MW1074A1 (no)
NL (1) NL7403126A (no)
NO (1) NO741093L (no)
OA (1) OA04641A (no)
PH (1) PH12616A (no)
PL (1) PL90989B1 (no)
RO (1) RO63021A (no)
SE (1) SE411453B (no)
ZA (1) ZA741423B (no)
ZM (1) ZM5674A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208515A (en) * 1973-02-23 1980-06-17 Eli Lilly And Company 3-Halo cephalosporins
US4064343A (en) * 1974-04-01 1977-12-20 Eli Lilly And Company 3-Halo cephalosporins
US4260745A (en) * 1979-10-12 1981-04-07 Eli Lilly And Company 3-Halo cephalosporins
US4281116A (en) * 1979-10-12 1981-07-28 Eli Lilly And Company 3-Halo cephalosporins
US4252950A (en) * 1979-10-12 1981-02-24 Eli Lilly And Company 3-Halo cephalosporins
DE3851449T2 (de) * 1987-02-27 1995-03-16 Banyu Pharma Co Ltd Cephalosporinderivate, Verfahren zu ihrer Herstellung und antibakterielle Mittel.
JPH0343723A (ja) * 1989-07-11 1991-02-25 Japan Servo Co Ltd 投影器
WO1993011132A1 (de) * 1991-12-06 1993-06-10 Ciba-Geigy Ag Verfahren zur herstellung des antibiotikums cefaclor
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830808A (en) * 1968-06-14 1974-08-20 Glaxo Lab Ltd Cephalosporins having a thioetherified methyl group at the 3-position
GB1377651A (en) * 1971-01-12 1974-12-18 Glaxo Lab Ltd Esters

Also Published As

Publication number Publication date
ES427235A1 (es) 1976-07-16
FI99474A (no) 1975-08-07
IL44361A0 (en) 1974-06-30
DK119874A (no) 1975-09-29
IE38980B1 (en) 1978-07-05
DE2417988A1 (de) 1975-08-07
CA1017741A (en) 1977-09-20
IN139927B (no) 1976-08-21
ATA312174A (de) 1975-07-15
FR2259826A1 (no) 1975-08-29
MW1074A1 (en) 1975-07-09
SE7403307L (no) 1975-08-07
GB1462944A (en) 1977-01-26
JPS612678B2 (no) 1986-01-27
AU6640374A (en) 1975-09-11
JPS50108287A (no) 1975-08-26
US3926978A (en) 1975-12-16
AT329181B (de) 1976-04-26
OA04641A (fr) 1980-07-31
GT197432532A (es) 1975-09-25
ZA741423B (en) 1975-10-29
AR202209A1 (es) 1975-05-23
BR7404085A (pt) 1976-01-27
IL44361A (en) 1977-07-31
FR2259826B1 (no) 1977-06-24
IE38980L (en) 1975-08-06
BG25091A3 (en) 1978-07-12
PH12616A (en) 1979-07-05
RO63021A (fr) 1978-05-15
NL7403126A (nl) 1975-08-08
HU167748B (no) 1975-12-25
ZM5674A1 (en) 1977-04-21
EG11061A (en) 1976-11-30
NO741093L (no) 1975-09-01
BE813169A (fr) 1974-10-02
CH598263A5 (no) 1978-04-28
DD117465A5 (no) 1976-01-12
PL90989B1 (no) 1977-02-28

Similar Documents

Publication Publication Date Title
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO145075C (no) Kontinuerlig fremgangsmaate til fremstilling av alkoksysilaner
NO142196C (no) Fremgangsmaate for fremstilling av avfarvede kaldtvannsopploeselige tegarvestoffer
SE7513085L (sv) Forfarande for framstellning av etrar
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE431207B (sv) Forfarande for framstellning av tiazolidinderivat
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE427925B (sv) Forfarande for framstellning av o-hydroxibensylalkoholer
SE431547B (sv) Forfarande for framstellning av 3-metylencefamsulfoxider
SE7505751L (sv) Forfarande for framstellning av cefalosporiner
SE418395B (sv) Forfarande for framstellning av indanettiksyror
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar
NO149427C (no) Fremgangsmaate for fremstilling av fenyl- henholdsvis naftyl-uretaner.